Cohen & Steers (CNS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $68.98, +3.90% vs the prior close of $66.39.
- Volume 581.40K shares, 2.1x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
CNS jumps 3.9% to $68.98 on 2.1x normal volume. Closed at $68.98, +3.90% vs the prior close of $66.39. Day range $65.86–$69.62, opened at $66.42.
CNS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CNS jumps 3.9% to $68.98 on 2.1x normal volume
- Closed at $68.98, +3.90% vs the prior close of $66.39. Day range $65.86–$69.62, opened at $66.42.
- Volume was 581.40K shares, 2.1x its 50-day average of 271.76K — unusually heavy trading.
- Price is -10.4% vs its 50-day average ($76.99) and -3.9% vs its 200-day average ($71.75).
- 52-week range $58.39–$86.56; today's close sits at 38% of that range, 20.3% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 14, 2026 — CNS slides 3.6% to $66.39, a 3-month low, 4 down days in a row
- Closed at $66.39, -3.59% vs the prior close of $68.86. Day range $65.08–$69.20, opened at $68.79.
- Volume was 379.10K shares, 1.4x its 50-day average of 269.22K.
- Price is -14.1% vs its 50-day average ($77.29) and -7.4% vs its 200-day average ($71.72).
- 52-week range $58.39–$86.56; today's close sits at 28% of that range, 23.3% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — CNS ends flat (-0.2%) to $68.86, a 3-month low, 3 down days in a row
- Closed at $68.86, -0.19% vs the prior close of $68.99. Day range $67.99–$69.91, opened at $69.91.
- Volume was 320.80K shares, 1.2x its 50-day average of 267.98K.
- Price is -11.3% vs its 50-day average ($77.64) and -4.0% vs its 200-day average ($71.71).
- 52-week range $58.39–$86.56; today's close sits at 37% of that range, 20.4% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — CNS dips 0.4% to $68.99, a 3-month low
- Closed at $68.99, -0.39% vs the prior close of $69.26. Day range $68.72–$70.33, opened at $69.48.
- Volume was 228.00K shares, 0.9x its 50-day average of 267.59K.
- Price is -11.5% vs its 50-day average ($77.96) and -3.8% vs its 200-day average ($71.68).
- 52-week range $58.39–$86.56; today's close sits at 38% of that range, 20.3% below the 52-week high.
Oct 9, 2026 — CNS dips 2.1% to $69.26, a 3-month low
- Closed at $69.26, -2.05% vs the prior close of $70.71. Day range $69.13–$71.42, opened at $70.12.
- Volume was 286.00K shares, 1.1x its 50-day average of 266.02K.
- Price is -11.5% vs its 50-day average ($78.23) and -3.3% vs its 200-day average ($71.65).
- 52-week range $58.39–$86.56; today's close sits at 39% of that range, 20.0% below the 52-week high.
Oct 8, 2026 — CNS ends flat (+0.3%) to $70.71
- Closed at $70.71, +0.30% vs the prior close of $70.50. Day range $69.62–$71.20, opened at $71.12.
- Volume was 262.90K shares, 1.0x its 50-day average of 265.61K.
- Price is -9.9% vs its 50-day average ($78.47) and -1.3% vs its 200-day average ($71.62).
- 52-week range $58.39–$86.56; today's close sits at 44% of that range, 18.3% below the 52-week high.
Oct 7, 2026 — CNS dips 2.8% to $70.50, a 3-month low
- Closed at $70.50, -2.84% vs the prior close of $72.56. Day range $70.49–$73.13, opened at $72.81.
- Volume was 283.60K shares, 1.1x its 50-day average of 265.00K.
- Price is -10.4% vs its 50-day average ($78.69) and -1.5% vs its 200-day average ($71.58).
- 52-week range $58.39–$86.56; today's close sits at 43% of that range, 18.6% below the 52-week high.
Oct 6, 2026 — CNS dips 0.6% to $72.56
- Closed at $72.56, -0.63% vs the prior close of $73.02. Day range $72.34–$73.96, opened at $73.75.
- Volume was 224.30K shares, 0.8x its 50-day average of 265.63K.
- Price is -8.1% vs its 50-day average ($78.93) and +1.4% vs its 200-day average ($71.55).
- 52-week range $58.39–$86.56; today's close sits at 50% of that range, 16.2% below the 52-week high.
Oct 5, 2026 — CNS ends flat (+0.0%) to $73.02
- Closed at $73.02, +0.03% vs the prior close of $73.00. Day range $71.61–$74.19, opened at $74.19.
- Volume was 287.40K shares, 1.1x its 50-day average of 264.62K.
- Price is -7.7% vs its 50-day average ($79.10) and +2.1% vs its 200-day average ($71.50).
- 52-week range $58.39–$86.56; today's close sits at 52% of that range, 15.6% below the 52-week high.
Oct 2, 2026 — CNS ends flat (-0.2%) to $73.00
- Closed at $73.00, -0.16% vs the prior close of $73.12. Day range $72.37–$74.15, opened at $73.24.
- Volume was 172.70K shares, 0.6x its 50-day average of 267.50K.
- Price is -7.9% vs its 50-day average ($79.27) and +2.2% vs its 200-day average ($71.45).
- 52-week range $58.39–$86.56; today's close sits at 52% of that range, 15.7% below the 52-week high.
CNS latest news & SEC filings
Every SEC filing by or about CNS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Villani Edmond D received an award of 375 shares on Oct 1, 2026; now holds 4,869
- Villani Edmond D gifted 442 shares on Oct 2, 2026; now holds 4,427
- Villani Edmond D gifted 442 shares on Oct 2, 2026; now holds 32,025
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dolly Lisa received an award of 375 shares on Oct 1, 2026; now holds 3,171
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Thissen Karen Wilson received an award of 375 shares on Oct 1, 2026; now holds 2,906
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Smith Dasha received an award of 375 shares on Oct 1, 2026; now holds 10,642
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Aggarwal Reena received an award of 375 shares on Oct 1, 2026; now holds 17,789
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Connor Frank T received an award of 375 shares on Oct 1, 2026; now holds 24,759
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CNS
- Last results release: Oct 15, 2026 (8-K Item 2.02). Previous ones: Jul 16, 2026, Apr 16, 2026, Jan 22, 2026. Based on that rhythm, the next report is likely around Jan 14, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.06% (largest 3.9%).
- Liquidity: about 323.61K shares (≈$22.32M) trade per day on average.
- 52-week position: $68.98 vs a range of $58.39–$86.56 (38% of the range).
- Dividends: last ex-dividend date Aug 10, 2026 ($0.67/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 19 open-market buys, 6 sales; latest: Elena Dulik sold 1,100 shares on Jul 20, 2026.
- Latest filings: 8-K Oct 15, 2026; 10-Q Jul 31, 2026; 8-K Jul 16, 2026.
- Share count: 51.42M shares outstanding (Jul 23, 2026), +0.8% vs a year earlier.
- Listing: NYSE · industry: Investment Advice.
CNS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 66.42 | 69.62 | 65.86 | 68.98 | 581.40K |
| Oct 14, 2026 | 68.79 | 69.20 | 65.08 | 66.39 | 379.10K |
| Oct 13, 2026 | 69.91 | 69.91 | 67.99 | 68.86 | 320.80K |
| Oct 12, 2026 | 69.48 | 70.33 | 68.72 | 68.99 | 228.00K |
| Oct 9, 2026 | 70.12 | 71.42 | 69.13 | 69.26 | 286.00K |
| Oct 8, 2026 | 71.12 | 71.20 | 69.62 | 70.71 | 262.90K |
| Oct 7, 2026 | 72.81 | 73.13 | 70.49 | 70.50 | 283.60K |
| Oct 6, 2026 | 73.75 | 73.96 | 72.34 | 72.56 | 224.30K |
| Oct 5, 2026 | 74.19 | 74.19 | 71.61 | 73.02 | 287.40K |
| Oct 2, 2026 | 73.24 | 74.15 | 72.37 | 73.00 | 172.70K |
| Oct 1, 2026 | 73.72 | 74.17 | 72.12 | 73.12 | 353.70K |
| Sep 30, 2026 | 73.47 | 73.90 | 72.96 | 73.11 | 330.40K |
| Sep 29, 2026 | 74.60 | 74.60 | 72.26 | 72.95 | 331.90K |
| Sep 28, 2026 | 74.34 | 74.46 | 72.82 | 73.77 | 497.80K |
| Sep 25, 2026 | 75.17 | 75.83 | 73.01 | 74.20 | 280.00K |
| Sep 24, 2026 | 75.78 | 76.79 | 74.56 | 75.15 | 323.30K |
| Sep 23, 2026 | 74.12 | 76.34 | 73.81 | 75.44 | 393.70K |
| Sep 22, 2026 | 75.03 | 75.03 | 72.87 | 74.54 | 273.60K |
| Sep 21, 2026 | 74.05 | 75.02 | 73.09 | 74.43 | 253.10K |
| Sep 18, 2026 | 72.67 | 74.04 | 71.97 | 73.79 | 408.50K |
About Cohen & Steers
Cohen & Steers (CNS) is listed on the NYSE and classified by the SEC under “Investment Advice”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1284812.
CNS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Reena Aggarwal | Director | Jul 6, 2026 |
| Martin Cohen | Director | Jul 6, 2026 |
| Frank T Connor | Director | Jul 6, 2026 |
| Lisa Dolly | Director | Jul 6, 2026 |
| Joseph M Harvey | Chief Executive Officer | Aug 21, 2026 |
| Robert Hamilton Steers | Executive Chairman | Feb 2, 2026 |
| Dasha Smith | Director | Jul 6, 2026 |
| Karen Wilson Thissen | Director | Jul 6, 2026 |
| Edmond D Villani | Director | Jul 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Brandon Brown | Executive Vice President | Aug 21, 2026 |
| Jon Cheigh | President and CIO | Aug 21, 2026 |
| Adam M Derechin | Chief Operating Officer, EVP | Aug 21, 2026 |
| Michael T. Donohue | Interim CFO, SVP | May 22, 2026 |
| Elena Dulik | Chief Accounting Officer, SVP | Aug 21, 2026 |
| Joseph M Harvey | Chief Executive Officer | Aug 21, 2026 |
| Amit Muni | Chief Financial Officer, EVP | Aug 21, 2026 |
| Daniel Noonan | Executive Vice President | Aug 21, 2026 |
| Francis C Poli | GC, Secretary, EVP | Aug 21, 2026 |
| Robert Hamilton Steers | Executive Chairman | Feb 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 20, 2026 | Elena Dulik | Sale | 1,100 | $83.16 |
| Jun 16, 2026 | Daniel Noonan | Sale | 4,360 | $77.33 |
| May 26, 2026 | Jon Cheigh | Sale | 10,500 | $71.75 |
| Feb 12, 2026 | Francis C Poli | Sale | 10,000 | $65.73 |
| Feb 11, 2026 | Francis C Poli | Sale | 4,696 | $65.24 |
| Feb 11, 2026 | Francis C Poli | Sale | 5,000 | $66.00 |
| Nov 20, 2025 | Martin Cohen | Buy | 12,708 | $60.83 |
| Nov 19, 2025 | Robert Hamilton Steers | Buy | 6,000 | $59.86 |
| Nov 19, 2025 | Robert Hamilton Steers | Buy | 19,000 | $59.88 |
| Nov 19, 2025 | Martin Cohen | Buy | 22,633 | $59.50 |
| Nov 19, 2025 | Martin Cohen | Buy | 14,659 | $59.91 |
| Nov 18, 2025 | Martin Cohen | Buy | 50,000 | $59.69 |
| Nov 5, 2025 | Robert Hamilton Steers | Buy | 19,329 | $67.61 |
| Nov 4, 2025 | Robert Hamilton Steers | Buy | 27,292 | $67.95 |
| Nov 4, 2025 | Robert Hamilton Steers | Buy | 14,975 | $67.96 |
CNS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $153.22M | 2.97 | $-120.44M |
| Dec 31, 2024 | — | $151.26M | 2.97 | $96.69M |
| Dec 31, 2023 | — | $129.05M | 2.60 | $171.96M |
| Dec 31, 2022 | — | $171.04M | 3.47 | $61.68M |
| Dec 31, 2021 | — | $211.40M | 4.31 | $242.90M |
Latest balance sheet: total assets $900.98M, total liabilities $205.61M, cash $59.15M (as of Jun 30, 2026).
CNS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 15, 2026 | 8-K Item 2.02 (results) | $68.98 |
| Jul 16, 2026 | 8-K Item 2.02 (results) | $81.07 |
| Apr 16, 2026 | 8-K Item 2.02 (results) | $64.64 |
| Jan 22, 2026 | 8-K Item 2.02 (results) | $68.78 |
| Oct 16, 2025 | 8-K Item 2.02 (results) | $65.80 |
| Jul 17, 2025 | 8-K Item 2.02 (results) | $75.56 |
| Apr 16, 2025 | 8-K Item 2.02 (results) | $73.89 |
| Jan 22, 2025 | 8-K Item 2.02 (results) | $86.65 |
| Oct 16, 2024 | 8-K Item 2.02 (results) | $101.17 |
| Jul 17, 2024 | 8-K Item 2.02 (results) | — |
| Apr 17, 2024 | 8-K Item 2.02 (results) | — |
| Jan 24, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Investment Advice
Blackstone (BX)Apollo Global Management (APO)Kkr (KKR)Ares Management (ARES)Price T Rowe (TROW)Ameriprise Financial (AMP)Carlyle (CG)Blue Owl Capital (OWL)Invesco (IVZ)Evercore (EVR)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CNS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.